10-Q quarterly report · filed Oct 21, 2026

Johnson & Johnson (JNJ) Q3 2026 10-Q Quarterly Report

Short answer

Johnson & Johnson (JNJ) filed its Q3 2026 10-Q quarterly report on Oct 21, 2026 for the quarter ended Sep 27, 2026. Quarterly revenue was $25.4B (up 5.9% year over year) with net income of $210M.

Q3 2026 key financials · XBRL

Revenue
$25.4B
+5.9% YoY · +0.4% QoQ
Net income
$210M
−95.9% YoY · −96.2% QoQ
Gross margin
68.1%
EPS (diluted)
$0.08
−96.2% YoY · −96.5% QoQ

Source: XBRL data from the Johnson & Johnson (JNJ) Q3 2026 10-Q on SEC EDGAR. USD.

Johnson & Johnson Q3 2026 10-Q analysis

AI summary of MD&A and risk factor updates

Management Discussion & Analysis

  • Emerging risks: pricing pressure, patent expirations, litigation, tariffs, supply-chain disruptions
  • Planned Orthopaedics separation: timing, execution, and anticipated benefits remain uncertain

Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K

Other Johnson & Johnson quarterly reports

Ask about this quarter

Compare quarters, check guidance or see what insiders and funds did around the report.